MedTherapy Biotech logo — Cell, Gene and Immunological Therapies for Cancer

MedTherapy Biotech

Cell, Gene and Immunological Therapies for Cancer

Founded 2018 United States Quincy, United States 34 employees Biotechnology

General Information

Company Name MedTherapy Biotech
Founded Year 2018
Location United States Quincy, United States +1
Employees 34
Industries Biotechnology
Social

Get notified when MedTherapy Biotech moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About MedTherapy Biotech

MedTherapy Biotech is a Boston-based biotechnology firm specializing in the development and manufacturing of cell, gene, and immunological therapies for cancer treatment. The company's mission is to ensure accessibility and affordability of these cutting-edge treatments for cancer patients worldwide. Established in 2018, MedTherapy collaborates with prominent institutions such as Harvard Medical School, Merck, and the International Health Organization (IHO) to advance its innovative therapies. While cell, gene, and immunological therapies represent groundbreaking medical advancements, their high costs pose a significant barrier. MedTherapy is committed to addressing this challenge by partnering with a diverse range of organizations, including private and public institutions, academia, and non-profits both in the United States and globally. By forging strategic alliances and leveraging advanced technologies, the company aims to streamline production processes and establish cost-effective solutions, ensuring that these life-saving therapies are accessible to every cancer patient worldwide. With a focus on the biotechnology sector, MedTherapy Biotech is at the forefront of revolutionizing cancer treatment. As the company continues to pioneer innovative strategies and collaborations, it presents a compelling opportunity for potential venture capital investment.

Taxonomy: Cancer Therapy, Cell Therapy, Gene Therapy, Immunotherapy, Global Collaboration, Medical Research, Healthcare Accessibility, Affordable Treatment, Collaborative Partnerships

No funding data available for MedTherapy Biotech yet.

Get notified when MedTherapy Biotech raises funding

MedTherapy Biotech Alternatives & Competitors

MedTherapy Biotech vs

Momentous change has happened, and a cancer-free future is possible -- thanks to cell and gene thera...

10 employees
Health Care, Health and Wellness
MedTherapy Biotech vs
Genprex, Inc.
Genprex, Inc. United States

Genprex is a gene therapy company focused on developing life-changing technologies for patients with...

Post Ipo Equity
24 employees
Biopharma, Biotechnology
MedTherapy Biotech vs

Ginkgo Bioworks is building the leading platform for cell programming and biosecurity.

FAQ About MedTherapy Biotech

Cell, Gene and Immunological Therapies for Cancer
MedTherapy Biotech was founded in 2018.
MedTherapy Biotech is headquartered in Quincy, United States.
MedTherapy Biotech operates in the following industries: Biotechnology.
MedTherapy Biotech has approximately 34 employees.
Top alternatives and competitors to MedTherapy Biotech include Alliance for Cancer Gene Therapy, Genprex, Inc., Ginkgo Bioworks, CGT Global, bluebird bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MedTherapy Biotech and Alliance for Cancer Gene Therapy are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MedTherapy Biotech and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes